The impact of GLP-1 medications on weight loss is undeniable, but emerging research suggests the results may only be temporary. A growing body of evidence shows that when patients stop taking GLP-1 ...

Fractyl Health Inc. (NASDAQ:GUTS) is one of the best biotech penny stocks to buy according to analysts. On December 2, Fractyl Health announced positive six-month results from its open-label REVEAL-1 ...

Though post-apocalyptic stories have become an expectation in the film and TV industry, Vice Gilligan‘s 2025 sci-fi, Pluribus, pushes the boundaries. Set in his favorite setting, Albuquerque, New ...

A potential cure for type 1 diabetes has been identified by scientists in a new mouse study. In an animal study, researchers at Stanford School of Medicine discovered that resetting the immune system ...

There are 13 Achievements in Schedule 1 for you to earn as you build your empire. These range from recruiting your very first dealer to help you out to disposing of trash for additional cash. Use the ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. People with diabetes who were taking GLP-1 ...

Talk about a lucky charm. Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been shown to spur weight loss as well as ease knee ...

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...

New research reveals that young adults with higher body shame and weight concerns are more likely to consider GLP-1 medications, despite significant side effects, unless buffered by strong body ...